← Back to Search

Biological

Intra- and extra- articular LP-PRP Injection for Osteoarthritis

Phase 1
Waitlist Available
Led By Sean W Mulvaney, MD
Research Sponsored by Regenerative Orthopedics and Sports Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing whether one injection of leukocyte-poor platelet-rich plasma (LP-PRP) into the intra-articular (IA) space of the hip improves symptoms of hip OA over 12 months, and whether adding an injection into the surrounding extra-articular (EA) structures improves symptoms more.

Eligible Conditions
  • Degeneration
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hip Osteoarthritis Outcome Score for Joint Replacement (HOOS JR)
Numeric Rating Scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intra- and extra- articular LP-PRP InjectionExperimental Treatment1 Intervention
A single injection of LP-PRP will be administered to the intra- articular space and the extra- articular structures under ultrasound guidance at the first visit.
Group II: Intra-articular LP-PRP InjectionActive Control1 Intervention
A single injection of leukocyte poor platelet rich plasma (LP-PRP) will be administered to the intra-articular space under ultrasound guidance at the treatment visit.

Find a Location

Who is running the clinical trial?

EmCyte CorporationIndustry Sponsor
2 Previous Clinical Trials
117 Total Patients Enrolled
1 Trials studying Osteoarthritis
90 Patients Enrolled for Osteoarthritis
Regenerative Orthopedics and Sports MedicineLead Sponsor
Sean W Mulvaney, MDPrincipal InvestigatorRegenerative Orthopedics and Sports Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Ohio
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
Regenerative Orthopedics and Sports Medicine
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Regenerative Orthopedics and Sports Medicine: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis
2021. "A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04241354.
~23 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top